Blair William & CO Seagen Inc. Transaction History

Blair William & CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$191.51 - $216.16 $1.42 Million - $1.6 Million	-7,413 Reduced 10.22%	65,117 $13.8 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $2.45 Million - $2.69 Million	-13,040 Reduced 15.24%	72,530 $14 Million
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $2.29 Million - $3.64 Million	17,913 Added 26.48%	85,570 $17.3 Million
Q4 2022 Feb 10, 2023	BUY	$117.37 - $139.17 $132,862 - $157,540	1,132 Added 1.7%	67,657 $8.69 Million
Q3 2022 Nov 09, 2022	SELL	$135.27 - $180.11 $943,778 - $1.26 Million	-6,977 Reduced 9.49%	66,525 $9.1 Million

Q2 2022 Aug 10, 2022	SELL	$108.81 - $179.33 $3.66 Million - $6.03 Million	-33,643 Reduced 31.4%	73,502 $13 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $837,987 - $1.11 Million	-7,006 Reduced 6.14%	107,145 $15.4 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $193,039 - $258,424	1,354 Added 1.2%	114,151 $17.6 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $3.74 Million - $4.45 Million	26,223 Added 30.29%	112,797 $19.2 Million
Q2 2021 Aug 12, 2021	SELL	$135.08 - $161.1 $216,668 - $258,404	-1,604 Reduced 1.82%	86,574 $13.7 Million
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $462,171 - $641,278	-3,361 Reduced 3.67%	88,178 $12.2 Million
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $15.1 Million - $19.4 Million	91,539 New	91,539 $16 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.